Showing 49–49 of 49 results
-
CJC-1295 W/O DAC 5mg +5mg Ipamorelin
A research‑grade blend of CJC‑1295 (Without DAC) 5mg and Ipamorelin 5mg—optimized for studies on pulsatile GH‑release mechanisms and dual‑peptide signaling pathways.
-
Balanced 5mg + 5mg formulation for controlled peptide‑interaction studies
-
Combines short‑acting CJC‑1295 (W/O DAC) with selective Ipamorelin
-
Ideal for research on GH‑release dynamics, receptor engagement, and peptide synergy
-
High‑purity lyophilized powder to ensure maximum stability and reproducibility
-
Designed for laboratory and educational research only
-
